| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCGENETICS.108.833392 |
| P698 | PubMed publication ID | 20031562 |
| P50 | author | John Ioannidis | Q6251482 |
| P433 | issue | 1 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| genome-wide association study | Q1098876 | ||
| P304 | page(s) | 7-15 | |
| P577 | publication date | 2009-01-23 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Circulation: Cardiovascular Genetics | Q15816430 |
| P1476 | title | Prediction of cardiovascular disease outcomes and established cardiovascular risk factors by genome-wide association markers | |
| P478 | volume | 2 |
| Q56991525 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice |
| Q89490251 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repre |
| Q34046881 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres |
| Q36675455 | An overview of the genomics of metabolic syndrome. |
| Q24613965 | Association between a literature-based genetic risk score and cardiovascular events in women |
| Q35914994 | Association of PNPLA3 rs738409 and TM6SF2 rs58542926 with health services utilization in a population-based study |
| Q28655418 | Association of hypertension with coronary artery disease onset in the Lebanese population |
| Q34445934 | Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levels |
| Q37444380 | Combining Multiple Hypothesis Testing with Machine Learning Increases the Statistical Power of Genome-wide Association Studies |
| Q36065519 | Evaluation of genetic risk scores for prediction of dichotomous outcomes. |
| Q42081879 | Genetic Contributions to Intergroup Responses: A Cautionary Perspective |
| Q34787709 | Genetic cardiovascular risk prediction: will we get there? |
| Q33993060 | Genetic causes of high and low serum HDL-cholesterol |
| Q36925161 | Genetic contribution and associated pathophysiology in end-stage renal disease |
| Q33578097 | Genetic risk score of NOS gene variants associated with myocardial infarction correlates with coronary incidence across Europe |
| Q33717049 | Genetic variants and their interactions in the prediction of increased pre-clinical carotid atherosclerosis: the cardiovascular risk in young Finns study |
| Q34565573 | Genetics of Age-Related Macular Degeneration: Current Concepts, Future Directions |
| Q37418945 | Genetics of coronary artery disease: focus on genome-wide association studies |
| Q38018761 | Genetics of coronary artery disease: genome-wide association studies and beyond |
| Q34179026 | Genetics of coronary heart disease with reference to ApoAI-CIII-AIV gene region |
| Q36480665 | Genome-wide significant associations for variants with minor allele frequency of 5% or less--an overview: A HuGE review |
| Q35079924 | Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach |
| Q35172900 | Implications of discoveries from genome-wide association studies in current cardiovascular practice. |
| Q34559794 | Improved Prediction of Cardiovascular Disease Based on a Panel of Single Nucleotide Polymorphisms Identified Through Genome-Wide Association Studies |
| Q24642868 | Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples |
| Q53552847 | Methods to Assess Genetic Risk Prediction |
| Q36824746 | Mortality From Myocardial Infarction After the Death of a Sibling: A Nationwide Follow‐up Study From Sweden |
| Q35193558 | Mosaicism of mitochondrial genetic variation in atherosclerotic lesions of the human aorta. |
| Q33605821 | Nutrigenomics in cardiovascular medicine |
| Q36396620 | Personalised medicine: not just in our genes |
| Q44112220 | Population-based case-control association studies |
| Q37643740 | Predictive genetic testing for coronary artery disease |
| Q29248999 | Radiation and Circulatory Disease |
| Q36089235 | Randomized trial of personal genomics for preventive cardiology: design and challenges |
| Q44932696 | Researching genetic versus nongenetic determinants of disease: a comparison and proposed unification |
| Q57315146 | SNPboost: Interaction Analysis and Risk Prediction on GWA Data |
| Q90575870 | Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases |
| Q36712234 | The 1p13.3 LDL (C)-associated locus shows large effect sizes in young populations. |
| Q38020959 | The genetics of multiple sclerosis: an up-to-date review |
| Q43160799 | Triglyceride level modifying functional variants of GALTN2 and MLXIPL in patients with ischaemic stroke. |
Search more.